Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1971 Jan;41(1):140–153. doi: 10.1111/j.1476-5381.1971.tb09944.x

Studies on the inhibition of clearance of organic dyes by Saramycetin

D A Cooney, R D Davis, E R Homan, N Rakieten, U Schaeppi, G Vanatta
PMCID: PMC1702746  PMID: 5547757

Abstract

1. Saramycetin, a polypeptide antifungal antibiotic has been found to retard the clearance of sulphobromophthalein (BSP) in man. An explanation for this observation was sought in several lower species.

2. Doses of Saramycetin without effect on the other standard tests of hepatic function or on hepatic morphology profoundly altered the disposition of BSP and several other dyes in mice and dogs.

3. Saramycetin strongly inhibited the hepatic enzyme which conjugates BSP to reduced glutathione, provoked a regurgitation of BSP from the liver into the bloodstream, and was anticholeretic in the dog.

4. These diverse actions of Saramycetin may, in concert, explain the altered clearance of BSP. It is suggested that low doses of Saramycetin exert a pharmacological effect on certain hepatic excretory processes, whereas high doses are toxic.

Full text

PDF
140

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDRIOLE V. T., UTZ J. P., SABESIN S. M. Altered sulfobromophthalein metabolism in man induced by the antifungal agent X-5079C. Am Rev Respir Dis. 1961 Oct;84:538–548. doi: 10.1164/arrd.1961.84.4.538. [DOI] [PubMed] [Google Scholar]
  2. Baiotti G., Abrate M. La cromocoloscopia alla bromosulfaleina nella diagnosi differenziale degli itteri occlusivi intra ed extraepatici. Minerva Med. 1966 Sep 19;57(75):3038–3041. [PubMed] [Google Scholar]
  3. COMBES B., STAKELUM G. S. Conjugation of sulfobromophthalein sodium with glutathione in thioether linkage by the rat. J Clin Invest. 1960 Aug;39:1214–1222. doi: 10.1172/JCI104137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. COMBES B. THE IMPORTANCE OF CONJUGATION WITH GLUTATHIONE FOR SULFOBROMOPHTHALEIN SODIUM (BSP) TRANSFER FROM BLOOD TO BILE. J Clin Invest. 1965 Jul;44:1214–1224. doi: 10.1172/JCI105227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GRAFFLIN A. L., BAGLEY E. H. Studies of hepatic structure and function by fluorescence microscopy. Bull Johns Hopkins Hosp. 1952 Jun;90(6):395–437. [PubMed] [Google Scholar]
  6. GRUNBERG E., BERGER J., TITSWORTH E. Chemotherapeutic studies on a new antifungal agent, X-5079C, effective against systemic mycoses. Am Rev Respir Dis. 1961 Oct;84:504–506. doi: 10.1164/arrd.1961.84.4.504. [DOI] [PubMed] [Google Scholar]
  7. Goldstein J., Combes B. Spectrophotometric assay of the liver enzyme that catalyzes sulfobromophthalein-glutathione conjugation. J Lab Clin Med. 1966 May;67(5):863–872. [PubMed] [Google Scholar]
  8. Klaassen C. D., Plaa G. L. Determination of sulfobromophthalein storage and exertory rate in small animals. J Appl Physiol. 1967 Jun;22(6):1151–1155. doi: 10.1152/jappl.1967.22.6.1151. [DOI] [PubMed] [Google Scholar]
  9. LORBER S. H., OPPENHEIMER M. J., SHAY H., LYNCH P., SIPLET H. Enterohepatic circulation of bromsulphalein: intraduodenal, intraportal and intravenous dye administration in dogs. Am J Physiol. 1953 May;173(2):259–264. doi: 10.1152/ajplegacy.1953.173.2.259. [DOI] [PubMed] [Google Scholar]
  10. Maggio M. B., Fujimoto J. M. Effect of carbon tetrachloride on distribution of sulfobromophthalein in plasma and liver of mice. Toxicol Appl Pharmacol. 1966 Sep;9(2):309–318. doi: 10.1016/0041-008x(66)90126-8. [DOI] [PubMed] [Google Scholar]
  11. RINDERKNECHT H. A new technique for the fluorescent labelling of proteins. Experientia. 1960 Sep 15;16:430–431. doi: 10.1007/BF02178856. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES